Diffuse large B-cell lymphoma is a common type of non-Hodgkin’s lymphoma that also has a high rate of relapse. Common signs of a relapse include lymph node swelling, as well as the development of “B ...

Dictionary.com has crowned a set of numbers as its 2025 word of the year. It says it reserves that distinction for a word that reflects "social trends and global events that defined that year" and ...

If you have kids, you’ve probably heard them blurt out “6-7” recently, with emphasis on the seven. Something like six-seven. Gen Alpha are randomly repeating the numbers and laughing at the inside ...

Adverse Effects and Drug Interactions of Diffuse Alveolar Hemorrhage Treatments On chest radiography or high-resolution computed tomography, a patient with diffuse alveolar hemorrhage may show diffuse ...

The other shoe has dropped for Roche’s bid to move Columvi into earlier treatment of diffuse large B-cell lymphoma (DLBCL) in the U.S. The FDA has declined to approve Columvi, in combination with the ...

Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Cancer Center, Zhejiang Provincial People’s ...

Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD)–European Society of ...

Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous malignancy with challenges in treatment resistance and relapse. Single-cell RNA sequencing (scRNA-seq) has provided important insights ...

aDepartment of Internal Medicine, Section of Rheumatology, Allergy, and Immunology, Yale School of Medicine, New Haven, CT, USA bDivision of Rheumatology, Scleroderma Program, Department of Internal ...